/Investor DB

KdT Ventures — 2026 Investments

1 investments dated 2026 · listed companies and verified rows first · show all

TACIT THERAPEUTICStacittx.cominMar 2026

Tacit Therapeutics develops RNA-based gene therapy approaches by redirecting cellular splicing processes to repair mutated genes.

BiotechDeep TechHealthtechSan Francisco, US

Co-investorsEisai Innovation, Inc.Laurier Startup FundMitsui Global InvestmentMichigan Capital Network

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.